September 15, 2015 article Open access Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo Leukemia DOI: 10.1038/leu.2015.247 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 5 stored of 868 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells 2024 Cell stem cell article Engineering 3D Printing in Biomedical Research Open access 115 citations Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy 2024 Molecular Therapy — Methods & Clinical Development article Medicine CAR-T cell therapy research Open access 8 citations Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle 2023 Frontiers in Immunology article Medicine CAR-T cell therapy research Open access cited by 6 patents 177 citations Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy 2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine CAR-T cell therapy research Open access 2 citations T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes 2021 Nature Biotechnology article Medicine CAR-T cell therapy research Open access cited by 7 patents 36 citations 5 results References 0